AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18314230
Drug: Triacylglycerol oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triacylglycerol oil (25 g/day for 120 days)
Trial: 15780649
Drug: Lateral wedge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral wedge with subtalar strapping for less than 5 hours daily (short group), n=21
Trial: 15780649
Drug: Lateral wedge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral wedge with subtalar strapping for 5-10 hours daily (medium group), n=20
Trial: 15780649
Drug: Lateral wedge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lateral wedge with subtalar strapping for greater than 10 hours daily (long group), n=18
Trial: 12098171
Drug: Valdecoxib (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib (40 mg twice a day)
Trial: 12098171
Drug: Diclofenac (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (75 mg twice a day)
Trial: 6357892
Drug: Hydrocortisone butyrate
RxNorm normalized name: Hydrocortisone Butyrate
DrugBank: Hydrocortisone butyrate (DB14540)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrocortisone butyrate cream 0.1%
Trial: 27113290
Drug: Paricalcitol (PCT,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paricalcitol (PCT, 2 μg/day)
Trial: 20571804
Drug: 120 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 kVp and 1.8 ml/kg contrast agent (300 mgI/ml)
Trial: 20571804
Drug: 80 kVp
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 kVp and 1.2 ml/kg contrast agent
Trial: 18056526
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg/d maintenance dose
Trial: 18056526
Drug: Clopidogrel 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 150 mg/d maintenance dose
Trial: 16096437
Drug: Exemestane (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane (25 mg/day; n=172)
Trial: 12404032
Drug: Lornoxicam 8
RxNorm normalized name: lornoxicam 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 8 mg/day
Trial: 12404032
Drug: Lornoxicam 16
RxNorm normalized name: Lornoxicam 16 mg prolonged-release oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lornoxicam 16 mg/day
Trial: 7596218
Drug: Epalrestat (aldose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epalrestat (aldose reductase inhibitor), treated for one month
Trial: 2164706
Drug: Bovine rotavirus
RxNorm normalized name: human-bovine reassortant rotavirus strain G1 vaccine / human-bovine reassortant rotavirus strain G2 vaccine / human-bovine reassortant rotavirus strain G3 vaccine / human-bovine reassortant rotavirus strain G4 vaccine / human-bovine reassortant rotavirus strain P1A[8] vaccine Oral Suspension [RotaTeq]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine rotavirus vaccine RIT 4237
Trial: 31811463
Drug: Elosan therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elosan therapy (4-min sessions, twice/week for 28 days)
Trial: 31811463
Drug: Elosan therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elosan therapy
Trial: 28990439
Drug: Oral fennel
RxNorm normalized name: Fennel
DrugBank: Fennel (DB15615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral fennel (n=30)
Trial: 25675199
Drug: Lowest homoarginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lowest homoarginine quartile (<1.40 μmol/L)
Trial: 19770473
Drug: Telcagepant 50
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant 50 mg
Trial: 15274426
Drug: Thiopental (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (25 mg)
Trial: 15274426
Drug: Thiopental (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (50 mg)
Trial: 15274426
Drug: Thiopental (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (75 mg)
Trial: 15274426
Drug: Thiopental (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (100 mg)
Trial: 8319654
Drug: Chlorinated water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorinated water (20 ppm, 1.5 L per day)
Trial: 3546223
Drug: Pre-treatment transurethral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-treatment transurethral resection (TUR)
Trial: 27978579
Drug: Selumetinib 100
RxNorm normalized name: Sélumétinib
DrugBank: Selumetinib (DB11689)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selumetinib 100 mg orally per day plus MK-2206 135 mg orally once per week
Trial: 27978579
Drug: mFOLFOX (oxaliplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mFOLFOX (oxaliplatin 85 mg/m2 intravenous and fluorouracil 2400 mg/m2 intravenous infusion over 46-48 hours)
Trial: 25629634
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine (control)
Trial: 23948221
Drug: Continuous Positive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Positive Airway Pressure (CPAP) treatment after 6 months
Trial: 23948221
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (before CPAP)
Trial: 21481064
Drug: Platelet-rich plasma
RxNorm normalized name: PLATELET-RICH PLASMA, AUTOLOGOUS
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Platelet-rich plasma (PRP) applied on one side after FxCR treatment
Trial: 16231341
Drug: Group therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group therapy (GRP)
Trial: 15078380
Drug: Cardiac Analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Analgesic Assessment Scale (CAAS)
Trial: 10729392
Drug: Low fat
RxNorm normalized name: Low fat spread
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low fat meal (10 g fat)
Trial: 8854774
Drug: Arterial Embolization
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arterial Embolization Chemotherapy (AEC)
Trial: 8854774
Drug: Continuous Arterial
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous Arterial Infusion Chemotherapy (CAIC)
Trial: 1451218
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine sulphate (4 mg in 10 ml saline)
Trial: 1451218
Drug: Epidural saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline (10 ml saline)
Trial: 6091475
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 g preoperatively)
Trial: 30684970
Drug: Low-dose hCG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hCG at the time of GnRH-agonist trigger (Group 1)
Trial: 30684970
Drug: Low-dose hCG
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hCG at the time of oocyte retrieval (Group 2)
Trial: 15613414
Drug: Testosterone patches
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patches
Trial: 12296782
Drug: Elyzol Dental
RxNorm normalized name: Elyzol
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Elyzol Dental Gel
Trial: 6697637
Drug: Carteolol 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carteolol 0.5 to 60 mg daily
Trial: 17117002
Drug: Hybrid functional
RxNorm normalized name: Amaranthus hybridus pollen
DrugBank: Amaranthus hybridus pollen (DB15503)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid functional electrical stimulation therapy on extensor carpi radialis longus and brevis, extensor digitorum communis, and extensor indicis proprius muscles, once or twice a week for 4 months after motor point blocks at the spastic finger flexor muscles
Trial: 15065610
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 440 microg twice daily
Trial: 1586175
Drug: Exosurf (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exosurf (2 doses in 24 hours)
Trial: 1586175
Drug: Exosurf (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exosurf (4 doses in 36 hours)
Trial: 3802303
Drug: Pirenzepine 100
RxNorm normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine 100 mg/die/p.o.
Trial: 3802303
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg/die/p.o.
Trial: 27335049
Drug: Crisaborole topical
RxNorm normalized name: crisaborole topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crisaborole topical ointment, 2%, applied twice daily for 21 days
Trial: 27335049
Drug: Vehicle ointment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle ointment, applied twice daily for 21 days
Trial: 16114089
Drug: Butterbur extract
RxNorm normalized name: butterbur extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butterbur extract (Ze 339; 8 mg total petasine; one tablet thrice‐daily)
Trial: 16114089
Drug: Fexofenadine (Telfast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine (Telfast 180; one tablet once‐daily)
Trial: 10526824
Drug: Dexmedetomidine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.3 ng/ml
Trial: 10526824
Drug: Dexmedetomidine 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.6 ng/ml
Trial: 7726352
Drug: Morphine and
RxNorm normalized name: morphine and antispasmodics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine and Bupivacaine
Trial: 2247104
Drug: Nystatin (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nystatin (oral and vaginal)
Trial: 2247104
Drug: Placebo (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (oral and vaginal)
Trial: 6451637
Drug: 0.1 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg/day of 13‐cis‐retinoic acid
Trial: 6451637
Drug: 0.5 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg/day of 13‐cis‐retinoic acid
Trial: 6451637
Drug: 1.0 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg/day of 13‐cis‐retinoic acid
Trial: 28381530
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g protein (control)
Trial: 28381530
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g protein
Trial: 28381530
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g protein
Trial: 28381530
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g protein
Trial: 11485708
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (88 mg twice daily)
Trial: 9674734
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) - continuous i.v. infusion (450 U/kg/24 h, n = 6)
Trial: 9674734
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin (LMWH) - enoxaparin, s.c. treatment (1.5 mg/kg, n = 12)
Trial: 7988629
Drug: Diltiazem CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem CR 120 mg b.i.d. for 4 weeks
Trial: 7988629
Drug: Plain diltiazem
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain diltiazem tablets 60 mg q.i.d. for 4 weeks
Trial: 2522147
Drug: Intramuscular route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular route (IM group)
Trial: 2522147
Drug: Intradermal route
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal route (ID group)
Trial: 18047764
Drug: Anticonvulsant mood
RxNorm normalized name: ANTICONVULSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticonvulsant mood stabilizers (carbamazepine, valproic acid)
Trial: 12748244
Drug: 250 mg/d
RxNorm normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/d gefitinib
Trial: 12748244
Drug: 500 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg/d gefitinib
Trial: 10817716
Drug: Gemifloxacin 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 20 mg
Trial: 10817716
Drug: Gemifloxacin 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 40 mg
Trial: 10817716
Drug: Gemifloxacin 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 80 mg
Trial: 10817716
Drug: Gemifloxacin 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 160 mg
Trial: 10817716
Drug: Gemifloxacin 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 600 mg
Trial: 10817716
Drug: Gemifloxacin 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemifloxacin 800 mg
Trial: 2052460
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aminophylline and doxapram
Trial: 7083219
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (25 g orally at 12, 18, 24, 36, and 48 hours)
Trial: 28560383
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules daily for 3-6 weeks
Trial: 23432415
Drug: Netazepide 100
RxNorm normalized name: Netazepide
DrugBank: Netazepide (DB12355)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netazepide 100 mg
Trial: 23432415
Drug: Netazepide (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netazepide (various doses 5, 10, 25 mg)
Trial: 23432415
Drug: Netazepide (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netazepide (various doses)
Trial: 19111850
Drug: Drug and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug and nutritional supplements trials
Trial: 14987305
Drug: Mequitazine 10
RxNorm normalized name: mequitazine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mequitazine 10 mg
Trial: 14987305
Drug: Mequitazine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mequitazine 15 mg
Trial: 14987305
Drug: Dexchlorpheniramine 6
RxNorm normalized name: dexchlorpheniramine 6 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexchlorpheniramine 6 mg
Trial: 9135927
Drug: Miglitol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miglitol (50 mg t.i.d., followed by 100 mg t.i.d.)
Trial: 9135927
Drug: Glibenclamide (3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (3.5 mg q.d/b.i.d.)
Trial: 7970848
Drug: Ciprofloxacin (0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (0.1, 0.5, 1.0 micrograms/ml)
Trial: 3315645
Drug: 12 weeks
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12 weeks daily PMR instruction provided in class for academic credit (n = 51)
Trial: 28787759
Drug: Indocyanine green
RxNorm normalized name: Indocyanine Green
DrugBank: Indocyanine green (DB16024)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indocyanine green (ICG) fluorescence imaging (FI) at 0.25 mg per kg of patient weight injected intraoperatively after explorative laparotomy before CS.
Trial: 22587483
Drug: rosiglitazone (4-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone (4-8 mg/day)
Trial: 30699881
Drug: pioglitazone (15-45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone (15-45 mg/day)
Trial: 19922492
Drug: Cylindrical implant
RxNorm normalized name: Imperata cylindrica root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cylindrical implant (group A)
Trial: 19922492
Drug: Tapered implant
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tapered implant (group B)
Trial: 17448971
Drug: Iron ferrous
RxNorm normalized name: Ferrous Sulfate 325 MG Oral Tablet [IRON FERROUS SULFATE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron ferrous sulphate (256 mg/day; 80 mg of Fe(2+)), vitamin C (1000 mg/day), and folic acid (5mg/day) during the 30‐45 days preceding surgery (Group 2)
Trial: 15519131
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg LEV
Trial: 15519131
Drug: 2000 mg
RxNorm normalized name: bran 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2000 mg LEV
Trial: 12054147
Drug: Pamidronate (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate (60 mg iv weekly for three consecutive doses, followed by one infusion every 3 weeks for a total of 24 infusions)
Trial: 27546308
Drug: High-Fe formula
RxNorm normalized name: Slow-Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-Fe formula (6.6 mg Fe/d)
Trial: 27546308
Drug: Low-Fe formula
RxNorm normalized name: Slow-Fe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Fe formula (1.3 mg Fe/d)
Trial: 27546308
Drug: Fe drops
RxNorm normalized name: MaxFE Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fe drops (6.6 mg Fe/d)
Trial: 23582414
Drug: Optimal medical
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal medical therapy (MED)
Trial: 19127917
Drug: Intradermal needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal needle combined with Tuina therapy
Trial: 15014407
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (aspirin)
Trial: 9632034
Drug: Once-daily venlafaxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily venlafaxine (37.5 mg daily, increased up to 225 mg daily)
Trial: 9632034
Drug: Twice-daily venlafaxine
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily venlafaxine (37.5 mg daily, increased up to 225 mg daily)
Trial: 7890902
Drug: Interferon-alpha-2a therapy
RxNorm normalized name: Interferon alpha-2a
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2a therapy
Trial: 28401595
Drug: Cognitive music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive music training (12 bi-weekly 70-min sessions)
Trial: 28401595
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (12 bi-weekly 45-min sessions of gymnastic activities)
Trial: 21616512
Drug: High-dose insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose insulin therapy (5 mU·kg(‐1)·min(‐1) starting at skin incision)
Trial: 21616512
Drug: Standard metabolic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard metabolic care (target glycemia 6.0‐10.0 mmol/L, n = 10)
Trial: 18431002
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (EG) received four-day-in-a-row treatment with 10 degrees rightward deviating prisms.
Trial: 18431002
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) received four-day-in-a-row placebo treatment.
Trial: 18431002
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (EG) at one month post-treatment.
Trial: 18431002
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CG) at one month post-treatment.
Trial: 16918222
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTA) injections in ankle flexors, hamstrings, and adductors
Trial: 12787037
Drug: 0.1% fluocinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% fluocinolone acetonide solution (FAS)
Trial: 12787037
Drug: Both 0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both 0.1% fluocinolone acetonide solution and in orabase (FAS/FAO)
Trial: 3924533
Drug: Aspirin (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (650 mg qid) with Misoprostol (25 micrograms qid)
Trial: 3924533
Drug: Aspirin (650
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (650 mg qid) with Placebo
Trial: 24112149
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide (5 µg) via Respimat
Trial: 21821304
Drug: 16Gy boost
RxNorm normalized name: BOOST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16Gy boost dose
Trial: 21821304
Drug: Nomogram including
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Nomogram including histologic grade, DCIS, tumor diameter, age, tamoxifen, chemotherapy, and boost
Trial: 15170905
Drug: Leflunomide in
RxNorm normalized name: Product containing leflunomide in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide in combination with methotrexate (MTX)
Trial: 15170905
Drug: Leflunomide in
RxNorm normalized name: Product containing leflunomide in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide in combination with sulfasalazine